Modern Slavery and Human Trafficking Statement
(1st January 2025 till 31st December 2025)
1. Introduction
This statement is made pursuant to section 54(1) of the UK Modern Slavery Act 2015 (the “Act”) and sets out the steps Britannia Pharmaceuticals Limited (“Britannia”) has taken during the financial year ending 31st December 2025 to ensure that Modern Slavery and Human Trafficking (“MSHT”) are not taking place in our business or supply chains.
Britannia acknowledges its responsibilities under the Act and seeks to ensure that conditions for its employees are of a good standard and that none of its practices infringe on any legal or ethical requirements. Britannia takes a zero-tolerance approach to slavery and human trafficking and takes measures so far as reasonably possible to ensure that its business and supply chain are free from MSHT.
2. Our Organisation
Britannia is a UK based pharmaceutical company with approximately 95 UK based employees which is part of the STADA group of companies which operates globally with circa. 13,000 employees. Britannia’s primary expertise is in the development, marketing and distribution of STADA products in the UK in the therapeutic areas of Parkinson’s disease and the treatment of Schizophrenia.
3. Our Supply Chains
Britannia is a purchaser of materials, manufactured product, and services from around the world (including in EMEA, USA and Asia Pacific) which strives to conduct its business with partners, suppliers and third parties that share the same high ethical standards.
We recognise we work with suppliers in certain higher risk developing countries such as those in the regions listed above and source goods and services from other countries which do not operate at a developed country standard. As such, we recognise that some areas of our supply chain may carry higher risks of modern slavery, and we are committed to mitigating these risks.
4. Policies and Procedures at Britannia for the Modern Slavery Act
Britannia operates on the core values of Agility, Entrepreneurship, One STADA and Integrity, which ensure that Britannia and the STADA group of entities avoid working with organisations that may not comply with the Act any other relevant legislation on a global level.
Britannia operates the following policies that describe its approach to the identification of modern slavery risks and steps to be taken to prevent slavery and human trafficking in its operations:
• Compliance Reporting policy: Britannia encourages all its workers, customers and other business partners to report any concerns related to the direct activities, or the supply chains of, Britannia. This includes any circumstances that may give rise to an enhanced risk of slavery or human trafficking. Britannia’s Compliance Reporting procedure is designed to facilitate whistleblowing and the reporting of concerns regarding business conduct or decisions, and confidentially protected disclosures of information without fear of retaliation.
• Employee code of conduct: Britannia’s code of conduct makes clear to its employees the actions and behaviour that is expected of them when representing Britannia. Britannia strives to maintain the highest standards of employee conduct and ethical behaviour when operating both within the UK and abroad and when managing its supply chain.
• Supplier Code of Ethics: Britannia is committed to ensuring that its suppliers adhere to the highest standards of ethics. In advance of entering into contracts with Britannia, we strive to ensure all suppliers are required to demonstrate that they provide safe working conditions, treat workers with dignity and respect, and act ethically and within the law in their use of labour. Britannia’s suppliers are strongly encouraged to comply with Britannia’s Code of Ethics for procurement and supply practices (or their third party equivalent) and these are embedded into key commercial contracts with Britannia. Britannia works with suppliers to ensure that they meet the standards of the code and to improve their worker’s working conditions.
• Supplier Ethics Questionnaire: Effective 1st January 2017, all suppliers must complete an Ethics questionnaire prior to Britannia entering into a formal supply contract. The supplier will be required to provide information with regard to its policies on human rights and workplace conditions to ensure these are consistent with the requirements of the Universal Declaration of Human Rights and the International Labour Conventions.
5. Due Diligence Processes
Under the above policies and procedures, all countries in which Britannia operates or is looking to operate in will be assessed using the following sources of information:
• Walk Free Foundation listing of worst countries for child labour;
• The Global Slavery Index;
• The Child Labour Index; and
• Chartered Institute of Purchasing and Supply reference guidance.
Where a country is potentially deemed to have a high MSHT risk Britannia will take all reasonable steps to ensure all workers or business partners, suppliers and third parties have appropriate employment contracts with individuals, workers are of legal working age, and workers are paid a wage commensurate with the work that they do and in accordance with ethical supply chain practices where that work is carried out.
Our due diligence includes:
• A risk assessment of suppliers;
• Supplier self-assessment questionnaires and interactions to establish the working practices;
• The implementation of contractual clauses or standards requiring partner, supplier and third party compliance with relevant MSHT laws
6. Risk Assessment and Management
We identify and assess potential risk areas in our supply chains and take steps to mitigate them, including:
• Prioritising high-risk suppliers for audits
• Providing training to procurement teams
• Engaging with suppliers to improve labour practices
7. Training and Awareness
We provide training to relevant procurement and contracting employees to ensure they understand the risks of MSHT and how to report concerns.
8. Effectiveness and Performance Indicators
We measure our effectiveness by:
• Number the number of risk assessments conducted;
• Evaluating suppliers signing up to our Supplier Code of Conduct (or third party equivalent) and appropriately completing the Ethics questionnaire during the procurement process;
• Reports received and resolved through our Compliance reporting channels
9. Approval
This statement has been approved by the Board of Directors of Britannia Pharmaceuticals on 31st December 2025 and signed by the Managing Director as such on behalf of the Board of Directors, and will be reviewed annually.
Mr Robert Wood
Managing Director
31st December 2025